The Novo Nordisk Phase 3a trial (NCT05726253) in children aged 6 to 11 may eventually change clinical practice, but until those results are published and reviewed, the evidence-based answer is: do not use Ozempic in this age group
The long-term outlook remains uncertain
Active screening for medications that impair gastric emptying, combined with gastric ultrasound, should be incorporated as complementary strategies to enhance patient safety
They suppress appetite through different neurological mechanisms, covering more ground than either pathway can cover alone
The hourly locomotor activity was further analyzed at each five-minute interval (Fig
OCN is a small c-carboxyglutamate protein, which is synthesized only by mature cementoblasts, osteoblasts and odontoblasts, and its function is controlled by RUNX2 in the later-stage of mineralized tissues 35,36,37